Faes Farma - Stock

Faes Farma Revenue 2024

Faes Farma Revenue

486.9 M EUR

Faes Farma Dividend yield

4.08 %

Ticker

FAE.MC

ISIN

ES0134950F36

WKN

A0MKAC

In 2024, Faes Farma's sales reached 486.9 M EUR, a 7.92% difference from the 451.17 M EUR sales recorded in the previous year.

The Faes Farma Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2027e512.8457,94
2026e513.5757,85
2025e497.4659,73
2024e486.961,02
2023451.1765,86
2022438.7564,28
2021398.5663,33
2020380.2463,08
2019357.463,63
2018324.3162,94
2017274.5864,88
2016228.6466,13
2015204.7265,34
2014191.765,73
2013180.463,53
2012176.164,22
2011195.762,03
2010211.460,26
2009199.460,88
2008196.960,84
2007203.966,36
2006192.566,65
2005168.767,10
2004165.166,51

Faes Farma Aktienanalyse

What does Faes Farma do?

The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Faes Farma's Sales Figures

The sales figures of Faes Farma originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Faes Farma’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Faes Farma's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Faes Farma’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Faes Farma Stock

How much revenue did Faes Farma generate this year?

Faes Farma has achieved a revenue of 486.9 M EUR this year.

How much was the turnover of the company Faes Farma compared to the previous year?

The revenue of Faes Farma has increased by 7.92% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Faes Farma?

The revenue of Faes Farma is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Faes Farma measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Faes Farma so important for investors?

The revenue of Faes Farma is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Faes Farma pay?

Over the past 12 months, Faes Farma paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 4.08 %. For the coming 12 months, Faes Farma is expected to pay a dividend of 0.17 EUR.

What is the dividend yield of Faes Farma?

The current dividend yield of Faes Farma is 4.08 %.

When does Faes Farma pay dividends?

Faes Farma pays a quarterly dividend. This is distributed in the months of July, February, May, February.

How secure is the dividend of Faes Farma?

Faes Farma paid dividends every year for the past 24 years.

What is the dividend of Faes Farma?

For the upcoming 12 months, dividends amounting to 0.17 EUR are expected. This corresponds to a dividend yield of 4.44 %.

In which sector is Faes Farma located?

Faes Farma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Faes Farma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Faes Farma from 1/15/2024 amounting to 0.039 EUR, you needed to have the stock in your portfolio before the ex-date on 1/11/2024.

When did Faes Farma pay the last dividend?

The last dividend was paid out on 1/15/2024.

What was the dividend of Faes Farma in the year 2023?

In the year 2023, Faes Farma distributed 0.035 EUR as dividends.

In which currency does Faes Farma pay out the dividend?

The dividends of Faes Farma are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Faes Farma

Our stock analysis for Faes Farma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Faes Farma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.